Delisting risk
Fractyl Health (GUTS)
Develops clinical-stage therapies for obesity and type 2 diabetes through the gut and pancreas.
$0.7077
Pre-market−0.00 (−0.03%)
At close$0.7079(−0.03%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions83 holders · as of Mar 31, 2026 | 45.24% | 72.01M shares | |
| Insiders9 holders · as of Jun 15, 2026 | 5.09% | 8.10M shares | |
| Otherremainder | 49.67% | 79.06M shares |
159.18M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
83 holders · 72.01M shares · 18 new positions · 32 increased · 27 reduced · 33 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13.36M | 8.40% | +2.52M | May 15, 2026 |
| 683 Capital Management, LLC | 6.73M | 4.23% | +679.6K | May 15, 2026 |
| Pale Fire Capital SE | 5.92M | 3.72% | +2.71M | May 14, 2026 |
| Vanguard Capital Management LLC | 5.53M | 3.48% | +5.53Mnew | May 15, 2026 |
| Catalio Capital Management, LP | 5.49M | 3.45% | 0 | May 15, 2026 |
| General Catalyst Group Management, LLC | 4.88M | 3.07% | 0 | May 15, 2026 |
| Deer Management Co. LLC | 4.77M | 3.00% | 0 | May 15, 2026 |
| Maverick Capital Ltd | 3.97M | 2.50% | −273.7K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Peter Thielincl. Mithril LP, Mithril II LP +4 more | 13.40% | 6.41M | 13G | Nov 13, 2024 ↗ |
| Nantahala Capital Management, LLC | 9.99% | 16.12M | 13G | May 15, 2026 ↗ |
| Maverick Capital Management, LLCincl. Lee S. Ainslie III, Maverick Capital, Ltd. | 8.90% | 4.25M | 13G | Nov 14, 2024 ↗ |
| BVP VII Special Opportunity Fund L.P. | 5.40% | 2.58M | 13G | Feb 14, 2025 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 12, 2026 | Ajay Royandirector | Purchase | 23,000 | $0.8520 | 40,901 |
| Jun 10, 2026 | Harith Rajagopalandirector, officer: Chief Executive Officer | Purchase | 25,000 | $0.7301 | 540,557 |
| Jun 10, 2026 | Ian Sheffielddirector | Purchase | 35,000 | $0.7294 | 35,000 |
| Jun 10, 2026 | William Bradleydirector | Purchase | 68,493 | $0.7348 | 84,622 |
| Jun 8, 2026 | Weber Lara Smithofficer: Chief Financial Officer | Purchase | 20,000 | $0.6854 | 20,000 |
| Dec 4, 2025 | Harith Rajagopalandirector, officer: Chief Executive Officer | Purchase | 10,416 | $1.92 | 501,745 |
CongressHouse and Senate disclosures
Not reported.